Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amnio-Maxx-2
- Development stage
- Unknown
- Lead developer
- Royal Biologics
- Modality
- Tissue Cells → Other Cell Types → Cell Therapies
- Administration
- Topical, Surgical Application
01
Overview
Amnio-Maxx-2 is a human amniotic membrane allograft distributed by Halo Biologics. It is classified as a Human Cell, Tissue, and Cellular and Tissue-Based Product (HCT/P) and is utilized as a surgical scaffold or biological wound cover. The product is derived from donated placental tissue and processed to preserve the natural extracellular matrix, growth factors, and cytokines inherent in amniotic tissue. Amnio-Maxx-2 functions as a biological barrier and scaffold to support tissue repair and regeneration in various clinical applications, including orthopedic surgery, wound care, and sports medicine. It is typically provided in a dehydrated form and is designed to facilitate natural healing processes while reducing inflammation at the site of application.
- Brand names
- Amnio-Maxx-2Amnio-Maxx2Amnio-Maxx 2
- Other names
- Amniotic membrane allograftDehydrated amniotic membrane
Beyond the preview
Go deeper on Amnio-Maxx-2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amnio-Maxx-2.